Skip to main content
All lobbying filings

THERMO FISHER SCIENTIFIC INC.

Lobbying for THERMO FISHER SCIENTIFIC INC

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 13, 2026
Expenses
$280,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 11
 Lobbying activity 7

General discussions regarding impact of U.S. federal government workforce changes on industry.

General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. General discussions regarding domestic pharmaceutical manufacturing. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill. H.R. 9061: Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing (PREEMPT) Act - all provisions of the bill.

H.R. 5304/S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - provisions regarding FY26 NIH Funding. General discussions regarding government contract thresholds. Regulation for Federal Financial Assistance (OMB-2026-0034).

Preparedness products and services. General discussions around government contracting opportunities.

POWER Act; all provisions of the bill.

General discussions regarding trade and tariffs, including with respect to markets including China. United States-Mexico-Canada Agreement.

General discussions regarding the expiration of key provisions of the 2017 Tax Cuts and Jobs Act, and other tax-related priorities.

 Bills named in this filing 7
  • H.R. 5269
    RESULTS Act
  • S. 2761
    RESULTS Act
  • H.R. 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S. 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • H.R. 9061
    PREEMPT Act
  • H.R. 5304
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
  • S. 2587
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem